ClinicalTrials.gg
Not yet recruitingNCT07857304Updated Oct 15, 2026

Chest Ultrasound as Diagnostic and Prognostic Tool in Neonatal RDS

An observational study in Respiratory Distress Syndrome, Newborn and Neonatal Respiratory Distress, sponsored by Assiut University. Not yet recruiting. Open to participants aged Up to 24 Hours. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Assiut University · Observational

How we know

Updated Oct 15, 2026Title changedNewly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
82
Ages
Up to 24 Hours
Sex
All
01

Study summary

This cross-sectional study aims to evaluate the diagnostic accuracy of chest ultrasound in neonatal respiratory distress syndrome and to assess its potential prognostic value compared with chest X-ray.

Read the detailed description

Neonatal respiratory distress syndrome is a major cause of morbidity in preterm infants. Chest X-ray is traditionally used for diagnosis but involves ionizing radiation. Lung ultrasound is a bedside, radiation-free alternative that may also provide prognostic information.

This observational study will include preterm neonates (≤35 weeks of gestation) presenting with clinical respiratory distress within the first 24 hours of life. Chest ultrasound and chest X-ray findings will be compared to assess diagnostic performance and potential prognostic value.

02

Conditions studied

  • Respiratory Distress Syndrome, Newborn
  • Neonatal Respiratory Distress

Keywords

  • Lung ultrasound
  • Respiratory distress syndrome
  • Chest X-ray
  • Preterm neonates
  • Assiut
03

In context

Respiratory Distress Syndrome, Newborn

123 studies on the registry are indexed under Respiratory Distress Syndrome, Newborn; 24 are open to participants now.

This study's planned enrollment of 82 is below the median of 150 across 25 observational studies indexed under Respiratory Distress Syndrome, Newborn.

Browse Respiratory Distress Syndrome, Newborn studies →

Lead sponsor

Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 24 Hours
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Preterm neonates (≤35 weeks of gestation) with clinical respiratory distress presenting at Assiut University Children's Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Preterm neonates ≤35 weeks of gestation
  • Clinical signs of respiratory distress within the first 24 hours of life
  • Radiographic data suggestive of respiratory distress syndrome
  • Written from parents or legal guardians

Exclusion criteria

Exclusion Criteria:

  • - Major congenital anomalies of the respiratory system
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
82 participants (estimated)
Patient registry
No

Groups and cohorts

  • Single cohort: Preterm Neonates with Respiratory Distress

    Preterm neonates (≤35 weeks of gestation) presenting with clinical and radiographic signs of respiratory distress syndrome within the first 24 hours of life who will undergo both chest ultrasound and chest X-ray.

06

What researchers measure

Primary outcomes

  1. Sensitivity of chest ultrasound for diagnosis of respiratory distress syndrome

    Sensitivity of chest ultrasound for the diagnosis of respiratory distress syndrome in preterm neonates, using chest X-ray as the reference standard.

    Time frame: Baseline

Secondary outcomes

  1. Specificity of chest ultrasound

    Specificity of chest ultrasound for the diagnosis of respiratory distress syndrome.

    Time frame: Baseline

  2. Positive predictive value of chest ultrasound

    Positive predictive value of chest ultrasound for the diagnosis of respiratory distress syndrome.

    Time frame: Baseline

  3. Negative predictive value of chest ultrasound

    Negative predictive value of chest ultrasound for the diagnosis of respiratory distress syndrome.

    Time frame: Baseline

  4. Overall diagnostic accuracy of chest ultrasound

    Overall diagnostic accuracy of chest ultrasound for diagnosis of respiratory distress syndrome calculated as (true positives + true negatives) divided by total cases, using chest X-ray as reference standard.

    Time frame: Baseline

  5. Proportion of neonates with white lung appearance on ultrasound

    Proportion of preterm neonates showing white lung appearance on chest ultrasound.

    Time frame: Baseline

  6. Proportion of neonates with abnormal pleural line on ultrasound

    Proportion of preterm neonates showing abnormal or irregular pleural line on chest ultrasound.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2026
First posted
Oct 5, 2026
StartEst.
Sep 28, 2026
Primary completionEst.
Sep 28, 2027
CompletionEst.
Feb 25, 2028
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Title
Chest Ultrasound Versus Chest X-ray in Neonatal Respiratory Distress Syndrome→Chest Ultrasound as Diagnostic and Prognostic Tool in Neonatal RDS
Oct 15, 2026
Registered
First appeared on the registry
Oct 5, 2026
Show all 2 updates
  1. Oct 15, 2026
    Title Chest Ultrasound Versus Chest X-ray in Neonatal Respiratory Distress Syndrome→Chest Ultrasound as Diagnostic and Prognostic Tool in Neonatal RDS
    + 1 other change: description
  2. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07857304
Lead sponsor
Assiut University
Responsible party
Mariam Mousa Alisha (Resident Physician, Department of Pediatrics, Assiut University) — Principal investigator
First posted
Oct 5, 2026
Start date
Sep 28, 2026 (estimated)
Primary completion
Sep 28, 2027 (estimated)
Completion
Feb 25, 2028 (estimated)
Last update
Oct 15, 2026

Study contacts

Mariam m Elisha, Resident
Contact
mmariammousa@gmail.com
+20 12 08409555
Mohamed A fathy, prof
study chair · Pediatrics Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion